Learn about ReSurge’s evolving response to the Covid-19 pandemic
2020 brought many challenges to the world, and ReSurge experienced many. However, there were also some silver linings that came our way and ReSurge pivoted quickly to improve our reach and change our impact. We are looking forward to 2021 and will implement many of the changes put in place.
As a result of travel restrictions arising from the pandemic, we haven’t been able to send our surgical team or visiting educator trips into the field since March of 2020. Luckily, we still have our surgical outreach partners working directly in the countries we serve. Yet, early models predicted that COVID-19 led to the cancellation of 28 million surgeries just over a 12-week period, nearly 1 million are reconstructive surgical cases. As the world is adjusting to the pandemic, hospitals in many countries were slowly able to restart performing elective surgeries (i.e., those not required for immediate life-saving purposes).
In response to the changes, ReSurge adapted practices and took the opportunity to strengthen program delivery and advance our mission in new ways. Beginning in April and continuing to date, ReSurge averages one virtual training event every four days, resulting in training over 1,800 medical professionals in over 30 countries! We’ve conducted 64 lectures in the following categories: Anesthesia, Nursing, ReSurge Grand Rounds (General Grand Rounds, ICU Grand Rounds in Nepal, and Stanford Grand Rounds), Case Conferences, and Surgery. The results are extremely positive, with many more virtual lectures scheduled for the year ahead.
We view these virtual trainings as evidence of the evolution of ReSurge’s commitment to continual improvement in our training practices. One of our strategic goals has been to develop a more robust platform and set of practices for distance learning; as a result of COVID-19, we are accelerating this activity.
Additionally, we are advancing our Monitoring and Evaluation protocols and infrastructure to better document the impact of training which will enable us to continue our robust virtual training schedule as a complement to our hands-on programs.
While we have adapted and modified the way we work, due to the COVID-19 pandemic, we continue to have the important impact we always have in the countries ReSurge serves. We appreciate your support, which remains a critical element in our success. Click here click here to view an important video on how your donations help our partners around the world adjust to delivering reconstructive surgery during the pandemic.
President & CEO
April 22, 2020
COVID-19 has had a significant impact on ReSurge’s work, as is true with most organizations. As a result of travel restrictions arising from the pandemic, we haven’t been able to send our surgical mission trips or visiting educator trips into the field. Additionally, hospital systems in every country we serve have halted elective surgeries (i.e., those not required for immediate life-saving purposes) to free up hospital beds and medical professionals to treat COVID-19 patients.
In response to these changes, we are adapting our practices and taking this opportunity to strengthen our organization and advance our mission in other ways. To date, we have delivered lecture-based training via videoconference to medical professionals in Zimbabwe and Vietnam. The initial feedback has been favorable and we have several more virtual seminars scheduled.
We view these seminars as proof points in the evolution of our training practices. One of our strategic goals has been to develop a more robust platform and set of practices around distance learning. This capability was meant to be rolled out in support of our expansion in eastern, central and southern Africa in 2021. Now, as a result of COVID-19, we are accelerating this activity and actively working on developing a robust, continuous distance learning capability.
Additionally, we are building out our monitoring and evaluation practices and infrastructure to better capture the impact from training so we can hit the ground running when this crisis has passed.
In short, while we are having to change the way we work, we continue to have an important impact in the countries we serve and are building capabilities to strengthen our organization for the long term. We appreciate your support, which remains a critical element in our success.
President & CEO
March 20, 2020
COVID-19 has turned the lives of most Americans upside down, including those of our dedicated volunteers. Our thoughts are with our them as, in many cases, they are on call to provide care to people in their own communities who may be suffering from the virus. Our hearts also go out to you and to all those who have been affected by this global pandemic.
To ensure the health and safety of our volunteers and respect the need for social distancing during this global pandemic, we are postponing all Visiting Educator and surgical team trips scheduled to take place through June 30, 2020. We will continue to assess our trip schedule as the situation evolves.
We want to reassure you, however, that our work continues. Our patients continue to need care to help them live independent lives of purpose. Our surgical outreach partners continue to treat patients who require reconstructive surgery, and to train up and coming surgeons to carry out this work. In fact, approximately 86% of our patients are treated by our partner surgeons in the countries we serve. This means that Nepalese reconstructive surgeons whom we fund are providing care to Nepalese patients, and Ecuadorean surgeons are providing care to Ecuadoreans.
So, we ask for your continued support as we (and you) grapple with the difficulties coronavirus presents. Your support ensures that our overseas partners will be able to continue treating patients who have suffered injuries or who were born with congenital conditions. And that means our patients will continue to be made whole by the surgical care we jointly provide.Thank you for your commitment to our mission as we all navigate this very challenging time.
President & CEO